Basit öğe kaydını göster

SERUM MATRIX METALLOPROTEINASE-9 LEVELS AND CARDIOVASCULAR RISK RATES IN SUBJECTS WITH METABOLIC SYNDROME

dc.contributor.authorUtku, Irem
dc.contributor.authorHarmankaya, Ozlem
dc.contributor.authorDemir, Esra
dc.contributor.authorKocoglu, Hakan
dc.contributor.authorUcak, Sema
dc.contributor.authorSerin, Sibel Ocak
dc.contributor.authorOKUTURLAR, Yıldız
dc.contributor.authorGEDİKBAŞI, Asuman
dc.date.accessioned2021-03-05T19:50:30Z
dc.date.available2021-03-05T19:50:30Z
dc.date.issued2015
dc.identifier.citationSerin S. O. , OKUTURLAR Y., GEDİKBAŞI A., Demir E., Utku I., Kocoglu H., Ucak S., Harmankaya O., "SERUM MATRIX METALLOPROTEINASE-9 LEVELS AND CARDIOVASCULAR RISK RATES IN SUBJECTS WITH METABOLIC SYNDROME", ACTA MEDICA MEDITERRANEA, cilt.31, ss.1271-1276, 2015
dc.identifier.issn0393-6384
dc.identifier.othervv_1032021
dc.identifier.otherav_d123c034-6a0d-4be6-bdcf-9075af79f016
dc.identifier.urihttp://hdl.handle.net/20.500.12627/138251
dc.description.abstractIntroduction: The present study aimed to evaluate and to compare Framingham Risk Score (FRS), a prediction tool for 10 year risk of coronary heart disease, and Matrix Metalloproteinase-9 (MMP-9) levels (an atherosclerotic proinflammatory marker) in patients with metabolic syndrome (MetS).
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleSERUM MATRIX METALLOPROTEINASE-9 LEVELS AND CARDIOVASCULAR RISK RATES IN SUBJECTS WITH METABOLIC SYNDROME
dc.typeMakale
dc.relation.journalACTA MEDICA MEDITERRANEA
dc.contributor.departmentIstanbul Umraniye Training & Research Hospital , ,
dc.identifier.volume31
dc.identifier.issue6
dc.identifier.startpage1271
dc.identifier.endpage1276
dc.contributor.firstauthorID2215057


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster